My site

LONDON-Wednesday 22 January 2020 [ AETOS Wire ]

(BUSINESS WIRE) -- I Squared Capital, through its ISQ Global Infrastructure Fund II, and Rubis (EPA: RUI), listed on Euronext Paris and a Paris-based company specializing in the distribution of petroleum products and bulk liquid storage, have signed an agreement to form a joint venture partnership through an investment in Rubis Terminal, a wholly-owned subsidiary of Rubis. I Squared Capital will acquire 45 percent of the shares in Rubis Terminal and will jointly control the company alongside Rubis.

With a portfolio of 13 facilities and a capacity of 3.5 million cubic meters across four countries, Rubis Terminal provides critical bulk-liquid storage infrastructure to a diversified base of industrial customers and across a broad range of petroleum, chemical and agri-food products. The partnership will accelerate Rubis Terminal’s strategic plan to strengthen its position within its current footprint, diversify its pr ... Read more »

• Full-year worldwide revenue of $32.9 billion was flat year-on-year, with international revenue growth of 7%
• Full-year GAAP loss per share, including charges & credits, was $7.32
• Full-year EPS, excluding charges & credits, was $1.47
• Full-year cash flow from operations and free cash flow were $5.4 billion and $2.7 billion, respectively
• Fourth-quarter revenue of $8.2 billion decreased 4% sequentially, with international revenue growth of 2%
• Fourth-quarter GAAP EPS, including charges & credits, was $0.24
• Fourth-quarter EPS, excluding charges & credits, was $0.39
• Fourth-quarter cash flow from operations and free cash flow were $2.3 billion and $1.5 billion, respectively
• Board approves quarterly cash dividend of $0.50 per share

HOUSTON-Tuesday 21 January 2020 [ AETOS Wire ]

(BUSINESS WIRE) -- Schlumberger Limited (NYSE: SLB) today reported r ... Read more »

GRAND CAYMAN, Cayman Islands-Tuesday 21 January 2020 [ AETOS Wire ]

(BUSINESS WIRE) -- The xx network has announced support of crypto pioneers, including Chris Larsen, for the initial Cayman sale of the xx coin starting on January 23, 2020.

The xx coin is a quantum secure digital currency designed to support and incentivize the decentralized ecosystem of the xx network, the revolutionary privacy-protecting blockchain led by David Chaum, founder of the Elixxir and Praxxis projects which underpin the xx network.

Chris Larsen, a serial entrepreneur, co-founder of the Ripple Network and longtime advocate for consumer privacy, said, "David Chaum has been a defender of privacy in the digital world for almost forty years. I am proud to be an early backer and look forward to seeing this consumer-facing blockchain open the door to secure use by millions of individuals in their daily lives."

Ownership and control of the xx network will be widely distr ... Read more »

MILAN-Tuesday 21 January 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- Ooredoo a leader in mobile services selected SIAE MICROELETTRONICA a leader supplier of microwave and millimetre wave radio technology for mobile backhaul to enhance its network in order to support increasing traffic in Algeria.

To meet new access technologies growing transport requirements as well as answering the growing data demand in the region, Ooredoo Algeria is modernizing its infrastructure by boosting capacity throughout the network. At this pro Ooredoo deploys SIAE MICROELETTRONICA multi-band link achieving fibre-like multi-gigabit capacity. A Multi-band link couples an 80GHz band with a standard frequency band, obtaining high capacity and longer reach for a given link. SIAE MICROELETTRONICA already provides connectivity in three of the five regions of the country.

SIAE MICROELETTRONICA has put in services the first two multi-band links in Blida and Boumerdes provinces transporting from ... Read more »

 Entertainment industry recognised accolade endorses Alibaba Cloud’s security, scalability and flexibility

HANGZHOU, China-Tuesday 21 January 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- Alibaba Cloud, the data intelligence backbone of Alibaba Group, has today announced that it is the first public cloud vendor in the world to obtain the prestigious Trusted Partner Network (TPN) certification, an achievement that validates the entertainment industry’s confidence in its robust security and trustworthiness as a cloud service provider. With viewing consumption habits changing rapidly, broadcast platforms constantly evolving and new production techniques emerging globally, Alibaba Cloud is successfully helping the entertainment industry to revolutionise how it works in order to respond to and embrace these changing dynamics by offering a highly secure, dependable, flexible and scalable cloud-based platform.

The TPN is a joint venture betwe ... Read more »

 Global Growth Investor General Atlantic Leads Series D Round

SAN FRANCISCO-Tuesday 21 January 2020 [ AETOS Wire ]

(BUSINESS WIRE) -- AppsFlyer, the global attribution leader, today announced a $210 million Series D funding round led by General Atlantic, a leading global growth equity firm based in New York. Alex Crisses, Managing Director at General Atlantic, and Anton Levy, Co-President and Global Head of Technology, have joined AppsFlyer’s Board of Directors.

“We are excited to partner with a company that has an experienced team and a culture focused on the customer,” said Alex Crisses, Managing Director, General Atlantic. “Attribution is becoming the core of the marketing tech stack, and AppsFlyer has established itself as a leader in this fast-growing category. AppsFlyer’s commitment to being independent, unbiased, and representing the marketer’s interests has garnered the trust of many of the world’s leadin ... Read more »

SINGAPORE.-Friday 17 January 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- Mundipharma today announced a partnership with Samsung Bioepis to commercialize Samsung Bioepis’ first-wave biosimilar candidates in Taiwan and Hong Kong.

The partnership covers Samsung Bioepis’ biosimilar candidates in the field of immunology and oncology, including SB5 (adalimumab), SB4 (etanercept), SB3 (trastuzumab), and SB8 (bevacizumab).

Through the partnership, Mundipharma will be the exclusive commercialization partner, while Samsung Bioepis will remain the Marketing Authorisation Holder (MAH), responsible for clinical development, regulatory registration, and manufacture of the biosimilars.

“This partnership brings together Samsung Bioepis’ proven biosimilar development platform with Mundipharma’s commercial acumen and market insight and ability to increase patient access to proven treatments,” said Mundipharma CEO, Raman Singh. “This ... Read more »